1.Krueger, JG. The immunologic basis for de treatment of psoriasis with new biologic agents. J Am Acad Derma­ tol. 2002; 46: 1-23.
2.Penn, H. Biologic therapies in autoimmune diseases. Clin Med 2006;6:105-8.
3.Sobell, J. Overview of Biologic Agents in medicine and dermatology. Semin Cutan Surg 24:2-9.
4.Johnston, S. Biologic therapies: what and when? J Clin Pathol 2007;60:8-17
5.Berger, M; Shankar, V; Vafai, A. Therapeutic applications of monoclonal antibodies. Am J Med Sci 2002; 324 (1): 14-30.
6.Nickoloff, B; Stevens, S. What have we learned in dermato­ logy from the biologic therapies?. J Am Acad Dermatol 2006;54:s143-51.
7.Kerns, M; Graves, J; Smith, D; Heffernan, M. Off-Label uses of biologic agents in dermatology: A 2006 update. Semin Cutan Med Surg 25:226 240.
8.Graves, J; Nunley K; Heffernan.M. Off-label uses of biologics in dermatology: Rituximab, omalizumab, infliximab, etanercept, adalimumab, efazilumab and alefacept. J Am Acad Dermatol 2007; 56: e55-79.